1. Home
  2. TNC vs MNMD Comparison

TNC vs MNMD Comparison

Compare TNC & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$73.91

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$13.43

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
MNMD
Founded
1870
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TNC
MNMD
Price
$73.91
$13.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$102.00
$30.33
AVG Volume (30 Days)
140.5K
2.0M
Earning Date
02-17-2026
11-06-2025
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
2.91
N/A
Revenue
$1,240,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.63
N/A
P/E Ratio
$25.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$67.32
$4.70
52 Week High
$90.44
$14.43

Technical Indicators

Market Signals
Indicator
TNC
MNMD
Relative Strength Index (RSI) 44.08 57.40
Support Level $74.67 $12.85
Resistance Level $75.87 $13.54
Average True Range (ATR) 1.47 0.69
MACD -0.12 0.05
Stochastic Oscillator 15.25 62.94

Price Performance

Historical Comparison
TNC
MNMD

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: